Akanda (AKAN) Other Non-Current Assets (2022 - 2025)
Akanda (AKAN) posted quarterly Other Non-Current Assets of $6.2 million for Q4 2025, down 21.71% year-over-year from $7.9 million in Q4 2024, and little changed quarter-over-quarter from $6.2 million in Q2 2025.
Akanda (AKAN) Other Non-Current Assets (2022 - 2025) Analysis & Trends
Akanda's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $6.2 million for Q4 2025.
- In Q4 2025, Other Non-Current Assets fell 21.71% year-over-year to $6.2 million; the TTM figure through Dec 2025 stood at $6.2 million (down 21.71% YoY), while the FY2025 annual figure was $6.2 million, down 21.71% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $6.2 million, roughly flat from $6.2 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $39.0 million in Q4 2022, with the low at $6.2 million in Q4 2025.
- The 4-year median for Other Non-Current Assets is $8.8 million (2023), against an average of $12.4 million.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets sank 77.33% in 2023, then climbed 12.73% in 2024.
- Akanda's Other Non-Current Assets stood at $39.0 million in 2022, then tumbled by 77.33% to $8.8 million in 2023, then slipped by 10.47% to $7.9 million in 2024, then slipped by 21.71% to $6.2 million in 2025.
- Business Quant data shows AKAN's Other Non-Current Assets at $6.2 million in Q4 2025, $6.2 million in Q2 2025, and $7.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 13.00 Mn |
| 10 | Akanda | 266,801.66 | 266,801.66 | - | 6.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.20 Mn |
| Jun 30, 2025 | 6.22 Mn |
| Dec 31, 2024 | 7.91 Mn |
| Jun 30, 2024 | 9.97 Mn |
| Dec 31, 2023 | 8.84 Mn |
| Jun 30, 2023 | 8.84 Mn |
| Dec 31, 2022 | 39.00 Mn |